Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Wiedermann

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 6, 2000
Rapid production of the major birch pollen allergen Bet v 1 in Nicotiana benthamiana plants and its immunological in vitro and in vivo characterizationM Krebitz, U Wiedermann, D Essl, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 27, 1999
Allergen mimotopes in food enhance type I allergic reactions in miceE Jensen-Jarolim, U Wiedermann, E Ganglberger, et al.
International Archives of Allergy and Immunology|April 18, 2001
IgE mimotopes of birch pollen allergen Bet v 1 induce blocking IgG in miceE Ganglberger, K Grünberger, U Wiedermann, et al.
The Journal of Allergy and Clinical Immunology|November 5, 1998
Bet v 1, the major birch pollen allergen, and Mal d 1, the major apple allergen, cross-react at the level of allergen-specific T helper cellsR Fritsch, B Bohle, U Vollmann, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 25, 1998
Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergenC Ebner, U Siemann, B Bohle, et al.
Clinical and Experimental Immunology|July 19, 2003
Induction of mucosal tolerance with recombinant Hev b 1 and recombinant Hev b 3 for prevention of latex allergy in BALB/c miceK Hufnagl, B Wagner, B Winkler, et al.
Allergy|January 18, 2006
The role of Foxp3+ T cells in long-term efficacy of prophylactic and therapeutic mucosal tolerance induction in miceB Winkler, K Hufnagl, A Spittler, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 7, 2003
Phage-displayed Bet mim 1, a mimotope of the major birch pollen allergen Bet v 1, induces B cell responses to the natural antigen using bystander T cell helpI Schöll, U Wiedermann, E Förster-Waldl, et al.
International Archives of Allergy and Immunology|October 20, 2001
Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in miceU Wiedermann, U Herz, K Baier, et al.
International Archives of Allergy and Immunology|April 18, 2001
Rapid production of recombinant allergens in Nicotiana benthamiana and their impact on diagnosis and therapyH Breiteneder, M Krebitz, U Wiedermann, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 6, 2000
Rapid production of the major birch pollen allergen Bet v 1 in Nicotiana benthamiana plants and its immunological in vitro and in vivo characterizationM Krebitz, U Wiedermann, D Essl, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 27, 1999
Allergen mimotopes in food enhance type I allergic reactions in miceE Jensen-Jarolim, U Wiedermann, E Ganglberger, et al.
International Archives of Allergy and Immunology|April 18, 2001
IgE mimotopes of birch pollen allergen Bet v 1 induce blocking IgG in miceE Ganglberger, K Grünberger, U Wiedermann, et al.
The Journal of Allergy and Clinical Immunology|November 5, 1998
Bet v 1, the major birch pollen allergen, and Mal d 1, the major apple allergen, cross-react at the level of allergen-specific T helper cellsR Fritsch, B Bohle, U Vollmann, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 25, 1998
Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergenC Ebner, U Siemann, B Bohle, et al.
Clinical and Experimental Immunology|July 19, 2003
Induction of mucosal tolerance with recombinant Hev b 1 and recombinant Hev b 3 for prevention of latex allergy in BALB/c miceK Hufnagl, B Wagner, B Winkler, et al.
Allergy|January 18, 2006
The role of Foxp3+ T cells in long-term efficacy of prophylactic and therapeutic mucosal tolerance induction in miceB Winkler, K Hufnagl, A Spittler, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 7, 2003
Phage-displayed Bet mim 1, a mimotope of the major birch pollen allergen Bet v 1, induces B cell responses to the natural antigen using bystander T cell helpI Schöll, U Wiedermann, E Förster-Waldl, et al.
International Archives of Allergy and Immunology|October 20, 2001
Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in miceU Wiedermann, U Herz, K Baier, et al.
International Archives of Allergy and Immunology|April 18, 2001
Rapid production of recombinant allergens in Nicotiana benthamiana and their impact on diagnosis and therapyH Breiteneder, M Krebitz, U Wiedermann, et al.
Pageof 5